基因治疗在肝脏移植中的应用进展
摘要
基因治疗应用于动物肝移植的研究已经具有可行性,有望在减少移植排异、诱导免疫耐受等方面取得突破,从而提高移植肝的存活时间,推动肝移植的发展。
出处
《上海生物医学工程》
2002年第4期43-45,共3页
Shanghai Journal of Biomedical Engineering
参考文献17
-
1Qin L, et al. Adenovirus mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther, 1997,8:1365-1374.
-
2Yang Y, Nunes FA, Berencsi K, Furth EE,Gonczol E, Wilson JM. Cellular immunity to viral antigen limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA,1994,91: 4407-4444.
-
3Kay MA, et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirusmediated gene transfer into mouse liver. Proc Natl Acad Sci USA, 1997,94,4686-4691.
-
4Shiraishi M, Kusano T. Adenovirus mediated gene transfer using in-situ perfusion of the liver graft. Transplantation International,1997,10:202-206.
-
5Takahashi, Y, Geller DA, Gambotto A,Watkins SC, Fung JJ, Murase N. A denovirusmed iated gene therapy to liver grafts: successful gene transfer by donor pretreatment. Surgery,2000, Aug; 128(2): 345-352.
-
6Shake A, Csete M, et al. Retrovial-mediated gene transfer into rat experimental liver transplant. Transplantation, 1994,57: 32.
-
7Chia SH, Geller DA, Kibbe MR, Watkins SC,Fung JJ, Starzl TE, Murase N. Adenovirus mediated gene transfer to liver grafts: an improved method to maximize infectivity.Transplantation, 1998, Dec, 15; 66 ( 11 ): 1545-1551.
-
8Olthoff KM, Da Chen X, Gelman A, Turka L,Shaked A. Adenovirus-mediated gene transfer of CTLA4Ig to liver allografts results in prolonged survival and local T cell energy.Transplant Proc, 1997,29:1030-1031.
-
9Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J,Lassman CR, Kolls JK, Alam J, Ritter T,Volk HD, Farmer DG, Ghbrial RM, Busuttil,RW, Kupiec Weglinski JW. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest, 1999 ,Dec, 104(11 ): 1631-1639.
-
10Lehmann, TG, Wheeler MD, Schoonhoven R, Bunzendahl H, Samulski RJ, Thurman RG. Delivery of Cu/Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver transplantation in the rat. Transplantation,2000 Mar,27; 69(6): 1051-1057.
-
1日本找到抑制肾移植排异新方法[J].中国社区医师,2008,24(14):21-21.
-
2黄九香,刘国平.霉酚酸酯治疗肾小球疾病的临床应用[J].中国中西医结合肾病杂志,2001,2(3):125-127. 被引量：5
-
3祝希媛.移植排异的免疫机理及胰岛移植排异研究进展[J].实用外科杂志,1990,10(6):287-289.
-
4马雄,邱德凯.肝移植与基因治疗[J].国外医学（消化系疾病分册）,1999,19(1):23-25.
-
5江志伟,黎介寿.器官移植的嵌合机理[J].医学研究生学报,1995,8(3):59-61. 被引量：1
-
6器官移植术[J].国外科技资料目录（医药卫生）,1999(10):53-53.
-
7Hammo.,E,张慧信.心脏移植排异病理[J].心肺血管病杂志,1994,13(3):174-175.
-
8王志生,彭晨,梁卫东,李立东.同种异体骨移植排异16例分析[J].中国组织工程研究与临床康复,2008,12(31):6148-6149. 被引量：7
-
9杨永岩,吴纪瑞,李铭山,崔维聪.尸体肾移植排异的X线、核素动态显象观察[J].福建医药杂志,1990,12(5):1-2. 被引量：1
-
10浙大郑树森院士领衔的肝移植研究取得突破[J].上海医药,2003,24(9):427-427.
